Write For Us

"Making Profit, But Not Enough To Reinvest," Says Adar Poonawalla

Sponsored Post Vitamin D2 Canada Persia
88 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
Adar Poonawalla Interview: The Serum Institute - makers of the Covishield vaccine - needs around Rs 3,000 crore to scale up production, CEO Adar Poonawalla told NDTV. "We are supplying the vaccine in the Indian market at approximately Rs 150-160. The average price of the vaccine is approximately $20 (Rs 1,500)... because of the Modi government's request, we are providing vaccines at subsidised rates... It is not that we are not making profits... but we are not making a super profit, which is key to re-investing," Mr Poonawalla told NDTV.

NDTV is one of the leaders in the production and broadcasting of un-biased and comprehensive news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Subscribe for more videos: https://www.youtube.com/user/ndtv?sub_confirmation=1
Like us on Facebook: https://www.facebook.com/ndtv
Follow us on Twitter: https://twitter.com/ndtv
Download the NDTV Apps: http://www.ndtv.com/page/apps
Watch more videos: http://www.ndtv.com/video?yt
Category
Asia
Tags
NDTV 24x7, Adar Poonawalla, Coronavirus
Sign in or sign up to post comments.
Be the first to comment